The Allstate Co. (NYSE:ALL) CFO Jesse E. Merten Sells 40,102 Shares

The Allstate Co. (NYSE:ALL) CFO Jesse E. Merten sold 40,102 shares of the firm’s stock in a transaction on Monday, February 10th. The stock was sold at an average price of $186.53, for a total transaction of $7,480,226.06. Following the completion of the sale, the chief financial officer now owns 18,115 shares in the company, valued at approximately $3,378,990.95. The trade was a 68.88 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link.

Allstate Stock Down 0.0 %

Shares of NYSE:ALL traded down $0.05 during midday trading on Wednesday, hitting $189.38. The stock had a trading volume of 2,641,333 shares, compared to its average volume of 1,786,019. The company has a quick ratio of 0.40, a current ratio of 0.36 and a debt-to-equity ratio of 0.42. The business’s 50-day simple moving average is $191.77 and its 200-day simple moving average is $189.48. The company has a market cap of $50.15 billion, a P/E ratio of 11.15, a PEG ratio of 1.47 and a beta of 0.52. The Allstate Co. has a 12 month low of $153.87 and a 12 month high of $209.88.

Allstate (NYSE:ALL) last issued its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, beating the consensus estimate of $5.40 by $2.27. Allstate had a net margin of 7.28% and a return on equity of 28.20%. On average, sell-side analysts forecast that The Allstate Co. will post 18.64 earnings per share for the current fiscal year.

Allstate Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were issued a dividend of $0.92 per share. The ex-dividend date was Friday, November 29th. This represents a $3.68 annualized dividend and a yield of 1.94%. Allstate’s payout ratio is currently 21.66%.

Analyst Ratings Changes

Several research firms have issued reports on ALL. Morgan Stanley raised their price target on shares of Allstate from $220.00 to $228.00 and gave the stock an “overweight” rating in a research report on Thursday, November 7th. UBS Group boosted their price target on Allstate from $216.00 to $225.00 and gave the company a “buy” rating in a research note on Monday, November 4th. Keefe, Bruyette & Woods raised their price objective on Allstate from $235.00 to $240.00 and gave the stock an “outperform” rating in a research report on Tuesday. BMO Capital Markets boosted their price objective on Allstate from $205.00 to $214.00 and gave the company an “outperform” rating in a research report on Friday, October 18th. Finally, Barclays reduced their target price on Allstate from $187.00 to $183.00 and set an “underweight” rating for the company in a research report on Monday, January 6th. One investment analyst has rated the stock with a sell rating, one has assigned a hold rating, fourteen have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $217.94.

Hedge Funds Weigh In On Allstate

Institutional investors and hedge funds have recently modified their holdings of the business. SPC Financial Inc. boosted its position in shares of Allstate by 3.6% during the 3rd quarter. SPC Financial Inc. now owns 1,564 shares of the insurance provider’s stock worth $297,000 after acquiring an additional 54 shares in the last quarter. Lake Street Advisors Group LLC lifted its stake in Allstate by 1.8% during the third quarter. Lake Street Advisors Group LLC now owns 3,129 shares of the insurance provider’s stock worth $596,000 after purchasing an additional 54 shares during the last quarter. Chicago Partners Investment Group LLC boosted its holdings in shares of Allstate by 1.3% in the 3rd quarter. Chicago Partners Investment Group LLC now owns 4,630 shares of the insurance provider’s stock valued at $893,000 after purchasing an additional 59 shares in the last quarter. Carmichael Hill & Associates Inc. increased its stake in shares of Allstate by 15.0% in the 3rd quarter. Carmichael Hill & Associates Inc. now owns 460 shares of the insurance provider’s stock valued at $87,000 after purchasing an additional 60 shares during the last quarter. Finally, Apella Capital LLC raised its holdings in shares of Allstate by 1.9% during the 4th quarter. Apella Capital LLC now owns 3,231 shares of the insurance provider’s stock worth $623,000 after buying an additional 60 shares in the last quarter. 76.47% of the stock is currently owned by institutional investors and hedge funds.

Allstate Company Profile

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.